The mechanism of dNTP-unbalanced cell death induced by 5-fluorouracil and its derivatives. 1985

A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya

The mechanism of 5-fluorouracil (5-FU) and 5-fluorodeoxyuridine (FdUR)-induced death of mouse mammary tumor FM3A cells was studied. When the cells were exposed to 5-FU or FdUR, an unbalance of intracellular dNTP pool resulted. The unbalance was followed by breakage of mature DNA. DNA double strand breaks were observed in the FdUR (1 microM) treated cells 16 hrs after the administration. We assume that the double strand breaks play an important role in the mechanism of the FdUR-mediated cell death. In addition, the activity that can induce DNA double strand breaks was detected in the lysate of FdUR treated FM3A cells. Since intracellular dNTP pool unbalance seems to be the trigger of these events, this phenomenon may be termed as dNTP-unbalanced cell death.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
January 1993, Nucleic acids symposium series,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
January 1992, Nucleic acids symposium series,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
October 1986, Chemico-biological interactions,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
September 2003, British journal of cancer,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
January 2020, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
October 1958, Proceedings of the National Academy of Sciences of the United States of America,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
January 2012, International journal of clinical and experimental pathology,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
May 1997, International journal of cancer,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
July 2002, Chinese medical journal,
A Yoshioka, and S Tanaka, and O Hiraoka, and Y Koyama, and Y Hirota, and Y Wataya
July 2022, Bioorganic chemistry,
Copied contents to your clipboard!